|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| License Fees | |||||
| Non-recurring Engineering | |||||
| Products | |||||
| Total revenues | |||||
| Cost of revenues: | |||||
| Products | |||||
| Non-recurring Engineering | |||||
| Loss on purchase commitment | |||||
| Total cost of revenues | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Gain from patent assignment | |||||
| Broker fee from patent assignment | |||||
| Operating income (loss) | |||||
| Interest income, net | |||||
| Other income | |||||
| Other income, net | |||||
| Income (loss) before provision (benefit) for income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net loss including noncontrolling interests | |||||
| Income (loss) from continuing operations | |||||
| Loss from discontinued operations | |||||
| Income (loss) from discontinued operations | |||||
| Net income (loss) | |||||
| Income (loss) per common share: | |||||
| Basic and diluted income (loss) per share from continuing operations (in dollars per share) | |||||
| Basic and diluted income (loss) per share from discontinued operations (in dollars per share) | |||||
| Basic and diluted net income (loss) per share(a) (in dollars per share) | |||||
| Basic and diluted – weighted average number of common shares outstanding (in shares) | |||||
| Diluted – weighted average number of common shares outstanding (in Shares) | |||||
Loading...